Testing version — LOERadar is in active testing. Features and data may change.
DIFFERIN (ADAPALENE) | LOERadar
DIFFERIN
NDA
ADAPALENE | N021753 | GALDERMA LABORATORIES LP
1 strength0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 0.3%
RLDAB
0 patents0 exclusivities▴
GEL;TOPICAL | Approved: Jun 19, 2007
No patent or exclusivity listings for this strength.